InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Biochemistry, Genetics and Molecular Biology » "Vitamin K2 - Vital for Health and Wellbeing", book edited by Jan Oxholm Gordeladze, ISBN 978-953-51-3020-8, Print ISBN 978-953-51-3019-2, Published: March 22, 2017 under CC BY 3.0 license. © The Author(s).

Chapter 5

The Impact of Vitamin K2 on Energy Metabolism

By Mona Møller, Serena Tonstad, Tone Bathen and Jan Oxholm Gordeladze
DOI: 10.5772/67152

  1. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S, et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Engl. N. Med. J. 360 (2009) 1518–1525.

  2. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 131 (2007) 242–256.

  3. Lowell BB, Susulic VS, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 366 (1993) 740–742.

  4. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. 454 (2008) 961–967.

  5. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 150 (2012) 366–376.

  6. Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26 (2012) 271–281.

  7. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481 (2012) 463–468.

  8. Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell. 106 (2001) 563–573.

  9. Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, Cohen P, Cinti S, Spiegelman BM. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J. Clin. Invest. 121 (2011) 96–105.

  10. Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 15 (2012) 395–404.

  11. Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, Rosenbaum M, Zhao Y, Gu W, Farmer SR, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell. 150 (2012) 620–632.

  12. Cohen P, Levy JD, Zhang Y, Frontini A, Kolodin DP, Svensson KJ, Lo JC, Zeng X, Ye L, Khandekar MJ, et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell. 156 (2014) 304–316.

  13. Lecka-Czernik B, Stechschulte LA. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). Arch. Biochem. Biophys. 561 (2014) 124–129.

  14. Aguirre L, Napoli N, Waters D, Qualls C, Villareal DT, Armamento-Villareal R. Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults. Clin. J. Endocrinol. Metab. 99(9) (2014) 3290–3297.

  15. Compston J. Obesity and bone. Curr. Osteoporos. Rep. 11 (2013) 30–35.

  16. Zhou C, Verma S, Blumberg B. The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl. Recept. Signal. 7 (2009) 1–21.

  17. Montminy M, and Koo SH. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Diabetes: outfoxing insulin resistance? Nature. 432 (2004) 958–9.

  18. Kodama S, Koike C, Negishi M. and Yamamoto Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 24 (2004) 7931–40.

  19. Miao J, Fang S, Bae Y. and Kemper JK. Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J. Biol. Chem. 281 (2006) 14537–46.

  20. Eaton S, Bartlett K. and Pourfarzam M. Mammalian mitochondrial β-oxidation. Biochem J. 320 (Pt 2) (1996) 345–57.

  21. Wolfrum C, Asilmaz E, Luca E, Friedman JM. and Stoffel M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 432 (2004) 1027–32.

  22. Kiyosawa N, Tanaka K, Hirao J, Ito K, Niino N, Sakuma K, Kanbori M, Yamoto T, Manabe S. and Matsunuma N. Molecular mechanism investigation of phenobarbital-induced serum cholesterol elevation in rat livers by microarray analysis. Arch. Toxicol. 78 (2004) 435–42.

  23. Bhalla S, Ozalp C, Fang S, et al. Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1a. Functional implications in hepatic cholesterol and glucose metabolism. J. Biol. Chem. 279 (2004) 45139–45147.

  24. Kodama S, Koike C, Negishi M, Yamamoto Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 24 (2004) 7931–7940.

  25. Kodama S, Moore R, Yamamoto Y, Negishi M. Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem. J. 407 (2007) 373–381.

  26. Konno Y, Kodama S, Moore R, et al. Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation. Mol. Pharmacol. 75 (2009) 265–271.

  27. Francis GA, Fayard E, Picard F, and Auwerx J. Nuclear Receptors and the Control of Metabolism. Ann. Rev. Physiol. 65 (2003) 261–311.

  28. Bügel S ,Vitamin K, and bone health in adult humans. Vitam. Horm. 78 (2008) 393–416.

  29. Ahmadieh H, Arabi A. Vitamins and bone health: beyond calcium and vitamin D. Nutr Rev. 69(10); (2011) 584–598. doi: 10.1111/j.1753-4887.2011.00372.x.

  30. Cheng J, Ma X, Krausz KW, et al. Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminopheninduced toxicity. Drug Metab. Dispos. 37 (2009) 1611–1621.

  31. Guo GL, Moffit JS, Nicol CJ, et al. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol. Sci. 82 (2004) 374–380.

  32. Nakamura K, Moore R, Negishi M, Sueyoshi T. Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J. Biol. Chem. 282 (2007) 9768–9776.

  33. Zhou J, Zhai Y, Mu Y, et al. A novel pregnane X receptormediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281 (2006) 15013–15020.

  34. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66 (1997) 581–611.

  35. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E671–E678.

  36. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem. J. 362 (2002) 513–532.

  37. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell. 59 (1989) 675–680.

  38. Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 413 (2001) 179–183.

  39. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: Insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85–96.

  40. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16 (2005) 183–189.

  41. Matsuzaki H, Daitoku H, Hatta M, et al. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. USA. 102 (2005) 11278–11283.

  42. Schmoll D, Walker KS, Alessi DR, et al. Regulation of glucose-6-phosphatase gene expression by protein kinase Ba and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and independent effects of insulin on promoter activity. J. Biol. Chem. 275 (2000) 36324–36333.

  43. Louet JF, Le May C, Pegorier JP, et al. Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids. Biochem. Soc. Trans. 29 (2001) 310–316.

  44. Hegardt FG. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: A control enzyme in ketogenesis. Biochem. J. 338 (1999) 569–582.

  45. Flowers MT, Ntambi JM. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr. Opin. Lipidol. 19 (2008) 248–256.

  46. Wolfrum C, Asilmaz E, Luca E, et al. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature. 432 (2004) 1027–1032.

  47. Weickert MO, Pfeiffer AF. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia. 49 (2006) 1732–1741.

  48. Zhou J, Zhai Y, Mu Y, et al. A novel pregnane X receptormediated and sterol regulatory element-binding protein-independent lipogenic pathway. J. Biol. Chem. 281 (2006) 15013–15020.

  49. Slatter JG, Templeton IE, Castle JC, Kulkarni A, Rushmore TH, Richards K, He Y, Dai X, Cheng OJ, Caguyang M, Ulrich RG. Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome. Xenobiotica. 36(10-11) (2006) 938–962.